At5g39000 Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Fundamentals

Antibodies (immunoglobulins) are Y-shaped proteins that bind specific antigens, enabling immune recognition and neutralization . Their structure includes:

  • Variable regions (VH/VL): Determine antigen specificity via complementary-determining regions (CDRs).

  • Constant regions (CH/CL): Mediate effector functions (e.g., complement activation, Fc receptor binding).

Antibodies are classified into isotypes (IgA, IgD, IgE, IgG, IgM) with distinct roles . For example, IgG dominates therapeutic antibodies due to its long half-life and effector capabilities .

Gene/Protein Nomenclature and Relevance

The designation "At5g39000" likely follows Arabidopsis thaliana gene nomenclature (e.g., AT5G39020 in source ). Such genes may encode proteins with roles in cellular processes, signaling, or stress responses. Antibodies targeting these proteins are critical for:

  • Protein localization studies (e.g., cytoplasmic vs. membrane-bound).

  • Functional assays (e.g., blocking enzymatic activity or protein-protein interactions).

For example, ATG5 antibodies (e.g., rATG5/2553) are used to study autophagy, B-cell polarization, and apoptosis . While At5g39000 remains uncharacterized, analogous antibodies for conserved antigens (e.g., MIF, HMGB1) have demonstrated therapeutic potential in sepsis and inflammation .

Antibody Development and Challenges

Generating antibodies against novel or conserved antigens requires specialized strategies:

ApproachAdvantagesApplications
NZB/W Mouse ImmunizationOvercomes tolerance to conserved antigensAnti-MIF, anti-HMGB1 antibodies
Chimeric Antibody DesignReduces cross-species binding issuesFlow cytometry, immunofluorescence
Recombinant ProductionHigh specificity and scalabilityTherapeutic IgG1/IgG4 variants

Key Challenges:

  • Low immunogenicity for conserved antigens .

  • Developability issues (e.g., aggregation, charge variants) .

Case Study: ATG5 Antibody (rATG5/2553)

ParameterDetailsSource
TargetHuman ATG5 (autophagy-related protein)
ApplicationsIHC-Paraffin, Protein Array
LocalizationCytoplasmic
FunctionAutophagy, apoptosis, antigen presentation

Mechanistic Insights:

  • Autophagy regulation: ATG5 interacts with FADD and Bcl-xl to modulate cell death .

  • Immune responses: Required for B-cell polarization and particulate antigen presentation .

Gaps and Future Directions

  1. Gene Annotation: No direct references to At5g39000 exist in public databases. Cross-referencing with Arabidopsis genome resources (e.g., TAIR) is critical.

  2. Antibody Validation: For novel targets, orthogonal validation (e.g., CRISPR knockout + antibody binding) is essential.

  3. Therapeutic Potential: Antibodies targeting plant proteins like At5g39000 may offer agricultural applications (e.g., pathogen resistance).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At5g39000 antibody; MXF12.2 antibody; Putative receptor-like protein kinase At5g39000 antibody; EC 2.7.11.- antibody
Target Names
At5g39000
Uniprot No.

Target Background

Database Links
Protein Families
Protein kinase superfamily, Ser/Thr protein kinase family
Subcellular Location
Membrane; Single-pass type I membrane protein.

Q&A

What is At5g39000 and why is it important in plant research?

At5g39000 is a gene in Arabidopsis thaliana that encodes a protein containing an RGD-binding motif. This protein is of significant interest in plant pathology research because it appears to be involved in plant-pathogen interactions, particularly in powdery mildew disease resistance mechanisms . The gene product has been studied in the context of plant cell wall biology and disease resistance pathways. Understanding the function of this protein contributes to our knowledge of how plants respond to pathogens and could potentially inform strategies for improving crop resistance to diseases. When designing experiments targeting this protein, researchers should consider its localization and potential interaction with cell wall components, as these factors may influence experimental outcomes.

How specific is the At5g39000 antibody for its target protein?

The At5g39000 antibody is designed to specifically recognize and bind to the protein encoded by the At5g39000 gene in Arabidopsis thaliana (Q9FID8) . To verify antibody specificity, researchers should perform validation experiments including Western blotting with positive and negative controls, immunoprecipitation followed by mass spectrometry, and comparative analysis using knockout/knockdown plant lines. Cross-reactivity with related proteins should be assessed, especially with other proteins containing RGD-binding motifs. When interpreting experimental results, consider that binding specificity can be influenced by the protein's conformational state, post-translational modifications, and the experimental conditions used.

What applications is the At5g39000 antibody suitable for?

The At5g39000 antibody is suitable for various immunological techniques in plant molecular biology research. These applications include Western blotting, immunoprecipitation, immunohistochemistry, ELISA, and immunofluorescence microscopy for protein localization studies. For optimal results in each application, researchers should determine the appropriate antibody concentration through titration experiments. In Western blotting, start with a 1:1000 dilution and adjust based on signal strength. For immunohistochemistry, tissue fixation methods significantly impact antibody performance, with aldehyde-based fixatives generally preserving antigen recognition sites. When using the antibody for co-immunoprecipitation to study protein-protein interactions, consider using gentle lysis buffers to maintain protein complex integrity.

How can I optimize immunolocalization of At5g39000 in plant cell wall studies?

Optimizing immunolocalization of At5g39000 in plant cell wall studies requires special consideration due to the protein's association with cell wall components . Begin by testing different fixation protocols to determine which best preserves both the antigen and cell wall structure. A combination of 4% paraformaldehyde with 0.1-0.5% glutaraldehyde often provides good results for maintaining cell wall architecture while preserving antibody epitopes. For cell wall proteins, enzymatic or chemical permeabilization should be carefully optimized - try a range of concentrations for cell wall degrading enzymes (0.1-1% cellulase, 0.05-0.5% macerozyme) and incubation times (15-60 minutes).

When blocking non-specific binding sites, use 3-5% BSA supplemented with 0.1-0.3% Triton X-100. For detecting low-abundance proteins like At5g39000, signal amplification systems such as tyramide signal amplification or quantum dots may improve detection sensitivity. Confocal microscopy with Z-stack acquisition is recommended for precise localization within cell wall layers. Always include appropriate controls: pre-immune serum, secondary antibody-only, and when possible, tissue from knockout mutants lacking At5g39000 expression.

What strategies can overcome cross-reactivity issues when studying At5g39000 in diverse plant species?

Cross-reactivity challenges often arise when using the At5g39000 antibody in non-Arabidopsis species due to protein sequence variations. To address this, first conduct in silico analysis to compare the At5g39000 sequence with homologs in your target species, focusing on the antibody's epitope region. Synthesize blocking peptides corresponding to the epitope sequence for pre-absorption experiments to confirm specificity. Consider using competitive ELISA to quantitatively assess cross-reactivity across species.

For Western blot applications in non-Arabidopsis species, increase stringency by using higher salt concentrations (150-300 mM NaCl) in wash buffers and optimize primary antibody concentration. Sequential immunoprecipitation with species-specific antibodies can help distinguish between true homologs and cross-reactive proteins. Additionally, validate all findings with complementary techniques such as mass spectrometry or RNA expression analysis. If persistent cross-reactivity issues occur, consider developing species-specific antibodies targeting unique regions of the homologous protein or employing epitope tagging strategies in transgenic plants.

How does the phosphorylation state of At5g39000 affect antibody recognition?

Post-translational modifications, particularly phosphorylation, can significantly impact antibody recognition of At5g39000. Since proteins with RGD-binding motifs are often regulated by phosphorylation, researchers should determine whether the At5g39000 antibody recognizes both phosphorylated and non-phosphorylated forms equally. To investigate this, perform parallel analyses using phosphatase-treated and untreated protein samples in Western blots. Consider using Phos-tag™ SDS-PAGE to separate phosphorylated from non-phosphorylated protein variants followed by immunoblotting.

For comprehensive analysis, combine the antibody-based detection with mass spectrometry to map phosphorylation sites and quantify their occupancy. If studying protein function under conditions that might alter phosphorylation status (such as pathogen challenge or stress treatments), monitor changes in antibody recognition patterns and correlate with functional outcomes. When designing experiments, include positive controls using recombinant proteins with defined phosphorylation states to establish detection thresholds and recognition efficiency.

What is the optimal protein extraction protocol for detecting At5g39000 in Arabidopsis tissues?

The optimal protein extraction protocol for At5g39000 detection must account for its association with cell wall components and potential membrane localization. Begin with 1-2 g of fresh plant tissue (preferably young leaves or seedlings) and grind to a fine powder in liquid nitrogen. Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS, supplemented with protease inhibitor cocktail. For membrane-associated proteins, include 1% NP-40 or digitonin as alternative detergents.

Include 10 mM DTT for reducing conditions and add 1-2% polyvinylpolypyrrolidone (PVPP) to remove phenolic compounds that may interfere with antibody binding. Extract for 30-45 minutes on ice with gentle agitation, then centrifuge at 15,000 × g for 20 minutes at 4°C. For enrichment of cell wall-associated proteins, consider fractionation approaches using sequential extraction with increasing concentrations of salt (0.2-1 M NaCl) and chelating agents (50 mM EDTA). Validate extraction efficiency using known cell wall and cytosolic protein markers. For quantitative studies, standardize protein loading using BCA or Bradford assays, preferably with BSA as the reference standard.

How should I design controls for immunoprecipitation experiments targeting At5g39000?

Robust controls are essential for reliable immunoprecipitation (IP) experiments with At5g39000 antibody. Include the following controls in your experimental design:

  • Input control: Reserve 5-10% of the pre-IP lysate to verify target protein presence before immunoprecipitation.

  • Negative antibody control: Perform parallel IP using the same concentration of isotype-matched non-specific antibody (typically rabbit IgG for polyclonal antibodies).

  • Pre-immune serum control: If available, use pre-immune serum from the same animal used to generate the At5g39000 antibody.

  • Genetic controls: Include samples from knockout/knockdown plants lacking At5g39000 expression to identify non-specific bands.

  • Peptide competition: Pre-incubate the antibody with excess synthetic peptide corresponding to the epitope region to block specific binding.

For co-immunoprecipitation experiments investigating protein-protein interactions, use reciprocal IP with antibodies against suspected interaction partners. Additionally, treat samples with crosslinking agents (1-2% formaldehyde for 10-15 minutes) to stabilize transient interactions, particularly for membrane or cell wall-associated complexes. Following IP, validate results using mass spectrometry to identify all proteins in the immunoprecipitated complex and confirm specificity with Western blot analysis.

What are the key considerations for using At5g39000 antibody in studying plant-pathogen interactions?

When using At5g39000 antibody to study plant-pathogen interactions, particularly in powdery mildew resistance mechanisms , several key considerations must be addressed. First, establish appropriate timepoints for protein analysis, typically including early (0-24 hours) and late (24-72 hours) stages post-inoculation to capture dynamic changes in protein levels and localization. Include both compatible (susceptible) and incompatible (resistant) interactions to differentiate pathogen-specific responses.

Careful sample preparation is critical; use gentle extraction methods to preserve protein complexes that may form during pathogen challenge. Consider using in situ techniques like immunofluorescence microscopy to visualize protein localization at infection sites, particularly focusing on cell wall appositions that form beneath attempted fungal penetration points. For such studies, thin sectioning (5-10 μm) followed by immunolabeling with the At5g39000 antibody provides better spatial resolution than whole-mount preparations.

When analyzing results, account for potential changes in antibody accessibility due to pathogen-induced cell wall modifications or protein conformational changes. Complement antibody-based studies with transcript analysis (RT-qPCR) to correlate protein expression with gene regulation. For functional studies, compare wild-type plants with pmr5 mutants to elucidate the role of cell wall components in disease resistance pathways associated with At5g39000 function.

How can I address weak or absent signals when using At5g39000 antibody in Western blots?

Weak or absent signals with At5g39000 antibody in Western blots may result from several factors requiring systematic troubleshooting. First, optimize protein extraction by using different lysis buffers (try RIPA, NP-40, or urea-based buffers) to ensure efficient solubilization of the target protein. For membrane-associated or cell wall proteins, include 0.1-0.5% SDS or 8M urea in extraction buffers to improve solubilization.

Adjust transfer conditions for high molecular weight proteins: use lower voltage (15-20V) for longer duration (overnight) at 4°C with 0.05-0.1% SDS in transfer buffer to facilitate movement of large proteins. For low abundance proteins, load more total protein (50-100 μg) and consider using enhanced chemiluminescence (ECL) substrates with higher sensitivity or fluorescent secondary antibodies for better quantification.

If signal remains weak, try alternative blocking agents (5% milk may cause less background than BSA for some antibodies) and extend primary antibody incubation to overnight at 4°C with gentle agitation. For antibodies recognizing conformational epitopes, avoid reducing agents or boiling samples before loading. Finally, verify target protein expression levels in your specific tissues and experimental conditions using RT-qPCR, as expression may vary with developmental stage or environmental conditions.

What methods can distinguish between specific and non-specific binding of At5g39000 antibody?

Distinguishing between specific and non-specific binding requires multiple validation approaches. Begin with peptide competition assays, where pre-incubating the antibody with 5-10 fold molar excess of the immunizing peptide should eliminate specific binding bands in Western blots but leave non-specific bands unaffected. Use genetic controls by comparing signal patterns between wild-type and knockout/knockdown plants; specific signals should be absent or significantly reduced in plants lacking At5g39000 expression.

Perform immunoprecipitation followed by mass spectrometry to identify all proteins recognized by the antibody and assess specificity. Include epitope-tagged recombinant At5g39000 protein as a positive control to confirm the expected molecular weight and recognition pattern. For immunohistochemistry or immunofluorescence applications, include absorption controls and secondary-only controls to identify background staining.

When analyzing data, be aware that post-translational modifications, alternative splicing, or protein degradation may result in multiple specific bands of different molecular weights. Document all experimental conditions thoroughly when publishing results, including antibody dilution, incubation time, and detection method to facilitate reproducibility.

How do I interpret changes in At5g39000 protein levels during powdery mildew infection studies?

Interpreting changes in At5g39000 protein levels during powdery mildew infection requires careful consideration of multiple factors. First, establish a reliable baseline by quantifying normal protein expression across different tissues and developmental stages in healthy plants. When monitoring infection time courses, normalize protein levels to appropriate loading controls – cytoskeletal proteins like actin may be preferable to housekeeping enzymes like GAPDH, which can fluctuate during stress responses.

Use densitometry software for quantitative Western blot analysis, performing at least three biological replicates with internal technical replicates. Compare protein level changes with transcript abundance measurements (RT-qPCR) to distinguish between transcriptional and post-transcriptional regulation. Be alert for changes in protein mobility that might indicate post-translational modifications rather than abundance changes.

Integrate protein data with functional assays to correlate At5g39000 levels with disease progression metrics (such as fungal biomass or host cell death). Given At5g39000's association with cell wall components and potential role in powdery mildew resistance , changes in subcellular localization may be as important as total protein levels. Use fractionation studies to track protein redistribution between cytosolic, membrane, and cell wall compartments during infection. Consider that protein turnover rates may change during infection, potentially requiring pulse-chase experiments for accurate interpretation of steady-state levels.

How can I use At5g39000 antibody in combination with other antibodies for co-localization studies?

Co-localization studies using At5g39000 antibody with other antibodies require careful planning to avoid cross-reactivity and signal interference. Begin by selecting secondary antibodies with spectrally distinct fluorophores that minimize bleed-through (e.g., Alexa 488 and Alexa 647). If both primary antibodies are from the same host species, use sequential immunolabeling with direct conjugation of one antibody to a fluorophore, or employ Zenon™ technology to pre-label one primary antibody before application.

For plant cell wall studies, use thin sections (3-5 μm) rather than whole mounts to improve resolution and antibody penetration. Apply primary antibodies sequentially rather than simultaneously if there's any concern about antibody cross-reactivity. Include appropriate controls: single-antibody staining controls, fluorophore-only controls, and ideally, genetic controls lacking one of the target proteins.

Analyze co-localization quantitatively using Pearson's correlation coefficient or Manders' overlap coefficient rather than relying on visual assessment alone. For proteins with partial co-localization, super-resolution microscopy techniques (STED, STORM, or SIM) can provide more definitive spatial relationships beyond the diffraction limit of conventional confocal microscopy. When studying protein-protein interactions, complement co-localization with proximity ligation assays or FRET analysis for more direct evidence of molecular proximity.

What are the considerations for using At5g39000 antibody in chromatin immunoprecipitation (ChIP) experiments?

Although At5g39000 protein primarily functions in cell wall-related processes , researchers investigating potential nuclear roles must carefully optimize ChIP protocols. First, verify nuclear localization using nuclear fractionation followed by Western blotting or immunofluorescence microscopy before attempting ChIP. For plant ChIP experiments, use 1-2% formaldehyde for precisely 10 minutes at room temperature for crosslinking, followed by quenching with 125 mM glycine.

Optimize sonication conditions to generate DNA fragments of 200-500 bp, typically requiring 10-15 cycles (30 seconds on/30 seconds off) at medium power for Arabidopsis tissue. Include appropriate controls: input DNA (non-immunoprecipitated, typically 5-10%), no-antibody control, and ideally, immunoprecipitation from plants lacking At5g39000 expression. For antibody selection, verify that the epitope recognized by the At5g39000 antibody remains accessible after crosslinking.

After immunoprecipitation, validate enrichment using qPCR with primers targeting predicted binding regions before proceeding to genome-wide analysis by ChIP-seq. If conducting ChIP-seq, prepare libraries from at least two biological replicates with appropriate sequencing depth (typically 20-30 million reads per sample). Use peak calling algorithms optimized for transcription factor ChIP (MACS2) with input sample as background. Follow up computational predictions with functional validation through reporter gene assays or targeted mutagenesis of putative binding sites.

How can nanobody-based approaches improve At5g39000 protein detection and functional studies?

Nanobody-based approaches offer several advantages for studying At5g39000 protein compared to conventional antibodies. Derived from camelid single-domain antibodies (VHH), nanobodies are significantly smaller (~15 kDa versus ~150 kDa for IgG), enabling better penetration into dense plant tissues and cell wall structures . To develop At5g39000-specific nanobodies, immunize alpacas or llamas with purified recombinant protein or specific peptides, followed by phage display screening of the VHH repertoire against the target protein.

For imaging applications, nanobodies can access epitopes in restricted spaces like the cell wall-plasma membrane interface that may be inaccessible to conventional antibodies. Their small size also reduces the distance between fluorophore and target in localization microscopy, improving spatial resolution for super-resolution techniques. Consider direct conjugation of fluorophores to nanobodies to eliminate secondary antibody requirements and reduce background.

For functional studies, express nanobodies intracellularly as "intrabodies" to track and potentially inhibit At5g39000 in living cells . Design expression constructs with appropriate targeting sequences to direct nanobodies to specific subcellular compartments where At5g39000 functions. For protein-protein interaction studies, nanobody-based proximity labeling (BioID or APEX) offers advantages over traditional co-immunoprecipitation by capturing transient interactions in living cells. When developing these tools, validate specificity using knockout lines and competition assays, as with conventional antibodies.

What emerging technologies are enhancing antibody-based research on plant cell wall proteins like At5g39000?

Recent technological advances are revolutionizing antibody-based research on plant cell wall proteins like At5g39000. Proximity-dependent labeling techniques such as TurboID and APEX2 are enabling in vivo identification of protein interaction networks in native cellular contexts. These approaches are particularly valuable for studying cell wall proteins, where traditional co-immunoprecipitation methods often disrupt important interactions.

Cryo-electron tomography combined with gold-labeled antibodies is improving our understanding of protein localization within the three-dimensional architecture of plant cell walls. This technique maintains the native state of cell wall structures while providing nanometer-scale resolution. Advanced mass spectrometry approaches, including cross-linking mass spectrometry (XL-MS), are increasingly being coupled with immunoprecipitation using antibodies like those against At5g39000 to characterize protein complexes with unprecedented detail.

Looking forward, antibody engineering technologies, inspired by therapeutic antibody development , will likely produce improved research reagents with enhanced specificity and sensitivity for plant proteins. The development of artificial intelligence approaches for antibody design, as demonstrated for pathogen targets , could be applied to generate superior plant protein antibodies. Additionally, the continued refinement of CRISPR-based epitope tagging will complement traditional antibody approaches by enabling the study of low-abundance proteins for which high-quality antibodies are difficult to generate.

How might understanding At5g39000 function contribute to broader plant pathology research?

Understanding At5g39000 function has significant implications for plant pathology research, particularly in deciphering cell wall-mediated defense mechanisms. The protein's RGD-binding motif suggests a role in cell adhesion or signaling processes at the cell wall-plasma membrane interface, potentially mediating recognition or response to pathogen invasion . By elucidating these mechanisms, researchers may identify conserved patterns of cell wall modification that contribute to broad-spectrum disease resistance.

The study of At5g39000 in powdery mildew resistance contexts provides a model for understanding how structural cell wall components influence the outcome of plant-pathogen interactions. This knowledge could inform breeding strategies for crop improvement by identifying cell wall traits that confer enhanced disease resistance without compromising agronomic performance. From a fundamental perspective, understanding At5g39000 function contributes to our knowledge of how plants balance growth and defense through cell wall dynamics.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.